The Global Fund Board

Despite challenges, including the missed targets at this 7th replenishment, the Global Fund remains one of the only organisations that enables civic space (the bedrock of any open and democratic society) at national levels. This inclusive partnership also takes place at the heart of the Global Fund’s own governance structures, where the two civil society Delegation from NGOs in Developed and Developing Countries and the Communities Delegations have power to influence decisions that have significant impact on policy and programmatic changes at the Global Fund.

The Delegations are essential in the Global Fund architecture as the Board embodies a partnership approach to global health. To help end the epidemics of HIV, TB and malaria, the Board incorporates leading stakeholders in an inclusive and effective way and in this Board the voice of civil society and communities are taken seriously.

The Board includes 20 voting members, with equal representation by implementers and donors. Non-governmental organizations: civil society and communities affected by HIV, TB and malaria; the private sector; and private foundations are also represented as voting members.

The Board was designed to have equality between those who contribute most financial resources to the Global Fund (The Donor Group) and those who implement programs (The Implementer Group).

The Implementer Group (ImG) is made up of the DCNGO Delegation as well as Communities Delegation; the DevDel Delegation; Eastern Europe and Central Asia (EECA); Eastern Mediterranean Region (EMRO); Eastern and Southern Africa (ESA); Latin America and Caribbean (LAC); Southeast Asia (SEA); Western and Central Africa (WCA); and the Western Pacific Region (WPR).

The Donor Group constituencies are Canada, Switzerland, and Australia; European Commission (Belgium, Finland, Italy, Portugal, Spain); France; Germany; Japan; Point Seven (Ireland, Denmark, Luxemburg, Netherlands, Norway, Sweden); United Kingdom, United States, Private Foundations; and the Private Sector.

Each constituency is represented by a Board Member (BM) and an Alternate Board Member (ABM).

In addition, there are eight Ex officio members without voting rights: the Board Chair and Vice-Chair; Executive Director; Partners (Roll Back Malaria, Stop TB Partnership, Partnership for Maternal and Newborn Child Health (PMNCH), and UNITAID); UNAIDS; the World Health Organization; the World Bank; and the Additional Public Donors constituency. The Additional Public Donors constituency was created by the Board to accommodate public donors that are not already represented by a voting constituency of the Board, according to eligibility requirements defined in the Global Fund bylaws.

The Board provides direction and oversees the development and implementation of a multi-year strategy for the Global Fund. Fighting Pandemics and Building a Healthier and More Equitable World: Global Fund Strategy (2023-2028) download in عربي | English | Español | Français | Português | Русский